Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Combination of Olmesartan and calcium channel blocker or low dose diuretics in high risk elderly hypertensive patients study (COLM-study)

Trial Profile

Combination of Olmesartan and calcium channel blocker or low dose diuretics in high risk elderly hypertensive patients study (COLM-study)

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2015

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Amlodipine; Azelnidipine; Indapamide; Thiazide diuretics; Trichlormethiazide
  • Indications Cardiovascular disorders; Essential hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms COLM
  • Most Recent Events

    • 17 Jun 2013 Tolerability results presented at the 23rd European Meeting on Hypertension.
    • 17 Jun 2013 Primary analysis presented at the 23rd European Meeting on Hypertension.
    • 01 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top